SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-164075
Filing Date
2018-05-15
Accepted
2018-05-15 16:06:50
Documents
45
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d493615d10q.htm 10-Q 306248
2 EX-31.1 d493615dex311.htm EX-31.1 6696
3 EX-31.2 d493615dex312.htm EX-31.2 6679
4 EX-32.1 d493615dex321.htm EX-32.1 2673
5 EX-32.2 d493615dex322.htm EX-32.2 3198
  Complete submission text file 0001193125-18-164075.txt   2304787

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ogen-20180331.xml EX-101.INS 298665
7 XBRL TAXONOMY EXTENSION SCHEMA ogen-20180331.xsd EX-101.SCH 35033
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ogen-20180331_cal.xml EX-101.CAL 27782
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ogen-20180331_def.xml EX-101.DEF 130232
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ogen-20180331_lab.xml EX-101.LAB 286920
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ogen-20180331_pre.xml EX-101.PRE 194125
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32188 | Film No.: 18836424
SIC: 2834 Pharmaceutical Preparations